DISCONTINUED OPERATIONS

9 Months Ended

Sep. 30, 2014

Discontinued Operations [Abstract]

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS

Results of operations for OralDNA, HemoCue and NID have been reported as discontinued operations for the three and nine months ended September 30, 2014 and 2013.

Discontinued operations, net of taxes, for the nine months ended September 30, 2013 includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to the Company's NID business and a gain of $14 million (including foreign currency translation adjustments, partially offset by income tax expense and transaction costs) associated with the sale of HemoCue.

Summarized financial information for the discontinued operations is as follows:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2014		2013			2014		2013
Net revenues	$	—	$	—		$	—	$	28
Income from discontinued operations before taxes	—		3			—		25
Income tax (expense) benefit	—		(1		)	—		10
Income from discontinued operations, net of taxes	$	—	$	2		$	—	$	35

The remaining balance sheet information related to HemoCue, OralDNA and NID was not material at September 30, 2014 and December 31, 2013.